share_log

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

輝瑞 | SC TO-I/A：發行招標公告
美股SEC公告 ·  08/22 11:19

Moomoo AI 已提取核心訊息

Pfizer Inc. has announced an amendment to its Tender Offer Statement on Schedule TO, filed with the SEC on August 12, 2024, regarding the Offer to Modify Eligible Performance Share Awards and Eligible Total Shareholder Return Units (TSRUs). The amendment, referred to as Amendment No. 1, supplements the original offer by removing references to continuous employment since July 24, 2024, and clarifying that all active employees of Pfizer and its wholly owned subsidiaries who hold Original Awards and reside in a country where Pfizer has granted Eligible TSRUs and/or Eligible PSAs are eligible to participate. The offer, which commenced on August 12, 2024, allows eligible participants to accept modifications to their performance share awards and TSRUs, potentially extending the performance period and vesting dates, among other changes. The expiration time for the offer is 11:59 p.m., Eastern Time, on September 12, 2024, unless extended. The offer is voluntary, and employees are not required to participate. Pfizer's stock, traded under the symbol 'PFE' on the NYSE, closed at $28.76 per share on August 8, 2024.
Pfizer Inc. has announced an amendment to its Tender Offer Statement on Schedule TO, filed with the SEC on August 12, 2024, regarding the Offer to Modify Eligible Performance Share Awards and Eligible Total Shareholder Return Units (TSRUs). The amendment, referred to as Amendment No. 1, supplements the original offer by removing references to continuous employment since July 24, 2024, and clarifying that all active employees of Pfizer and its wholly owned subsidiaries who hold Original Awards and reside in a country where Pfizer has granted Eligible TSRUs and/or Eligible PSAs are eligible to participate. The offer, which commenced on August 12, 2024, allows eligible participants to accept modifications to their performance share awards and TSRUs, potentially extending the performance period and vesting dates, among other changes. The expiration time for the offer is 11:59 p.m., Eastern Time, on September 12, 2024, unless extended. The offer is voluntary, and employees are not required to participate. Pfizer's stock, traded under the symbol 'PFE' on the NYSE, closed at $28.76 per share on August 8, 2024.
輝瑞公司已經宣佈修訂其提交給美國證券交易委員會於2024年8月12日的《全接待期貨與服務公司之最新變更草案》。草案是關於對可修改的績效股份獎勵與可修改的股東總回報單位（TSRU）的方案。修訂文檔，稱爲變更文檔第1號，通過刪除從2024年7月24日以來持續就業的提及，並澄清所有持有原始獎項並居住在輝瑞授予合格TSRU和/或合格PSA的國家內的輝瑞及其全資子公司的在職員工都有資格參與。該方案於2024年8月12日啓動，允許有資格的參與者接受對其績效股份獎勵和TSRU的修改，可能延長績效期和歸屬日期等其他變化。該方案的截止時間是2024年9月12日，東部時間晚上11:59，除非延長。方案是自願的，員工不需要參與。輝瑞的股票在紐交所上以「PFE」符號交易，截至2024年8月8日收盤價爲每股28.76美元。
輝瑞公司已經宣佈修訂其提交給美國證券交易委員會於2024年8月12日的《全接待期貨與服務公司之最新變更草案》。草案是關於對可修改的績效股份獎勵與可修改的股東總回報單位（TSRU）的方案。修訂文檔，稱爲變更文檔第1號，通過刪除從2024年7月24日以來持續就業的提及，並澄清所有持有原始獎項並居住在輝瑞授予合格TSRU和/或合格PSA的國家內的輝瑞及其全資子公司的在職員工都有資格參與。該方案於2024年8月12日啓動，允許有資格的參與者接受對其績效股份獎勵和TSRU的修改，可能延長績效期和歸屬日期等其他變化。該方案的截止時間是2024年9月12日，東部時間晚上11:59，除非延長。方案是自願的，員工不需要參與。輝瑞的股票在紐交所上以「PFE」符號交易，截至2024年8月8日收盤價爲每股28.76美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間